$1.35 - ZNTL | Zentalis Pharmaceuticals, Inc. Common Stock

Zentalis Pharmaceuticals, Inc. Common Stock (ZNTL)

Zentalis Pharmaceuticals, Inc. Common Stock

XNAS:ZNTL

1.35

-2.54%

Ask

$1.35 - 2,931.00

Bid

$1.34 - 1,900.00

Low

$1.34

High

$1.39

Open

$1.37

Prev Close

$1.38

52W High

3.33

52W Low

1.01

Volume

753757

Avg Vol (3m)

576999.8

Float

59498172.55

Chart

TendieTensor AI Analysis

Company

Asset Type: Common Stock

SIC Code: 2834

Sector: Health Technology

Industry: Biotechnology

Date Listed: 04/03/2020

Primary Exchange: XNAS

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.

Phone: (858) 263-4333

Address: 10275 Science Center Drive

Address 2: Suite 200

City: San Diego

State: CA

Postal Code: 92121

Website

TendieTensor AI Analyst Recommendation: —

Fundamentals

Total Employees:

166

P/E (TTM)

-0.660000

P/B (TTM)

0.399977

Round Lot

100

Composit FIGI

BBG00R2K8TF5

Share Class FIGI

BBG00R2K8TG4

Share Class Shares Outstanding

72.14M

Weighted Shares Outstanding

72.14M

Technicals

RSI (14)

MACD Line

MACD Signal

SMA 20

SMA 50

EMA 50

Trend

Short Interest

—

Days to Cover

— —

Higher = harder to cover

Short Interest Δ

—

Prev: —

Short Volume Ratio (Today)

— —

5D avg: —

Squeeze Score (0–100)

—

Discussion